Form 8-K - Current report:
SEC Accession No. 0000950170-22-022837
Filing Date
2022-11-08
Accepted
2022-11-08 06:02:53
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idya-20221108.htm   iXBRL 8-K 62461
2 EX-99.1 idya-ex99_1.htm EX-99.1 248474
3 GRAPHIC img107722786_0.jpg GRAPHIC 2663
  Complete submission text file 0000950170-22-022837.txt   454498

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idya-20221108.xsd EX-101.SCH 2477
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idya-20221108_lab.xml EX-101.LAB 14296
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idya-20221108_pre.xml EX-101.PRE 11394
8 EXTRACTED XBRL INSTANCE DOCUMENT idya-20221108_htm.xml XML 4901
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 221367056
SIC: 2834 Pharmaceutical Preparations